| ALT | alanine aminotransferase |
| αSMA | alpha smooth muscle actin |
| BDL | bile duct ligation |
| BM-MSCs | bone marrow mesenchymal stem cells |
| CCA | Cholangiocarcinoma |
| CCL2 | C-C motif chemokine ligand 2 |
| CCl4 | carbon tetrachloride |
| CCN2 | connective tissue growth factor |
| DILI | drug-induced liver injury |
| ECM | extracellular matrix |
| EVs | extracellular vesicles |
| HFFC | high saturated fat, high fructose, and high cholesterol |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HPC | hepatic progenitor cells |
| HSCs | hepatic stellate cells |
| hucMSCs | human umbilical cord mesenchymal stem cells |
| IL | Interleukin |
| lncRNAs | long non-coding RNAs |
| LPC | Lysophosphatidylcholine |
| LPS | Lipopolysaccharide |
| LSECs | liver sinusoidal endothelial cells |
| MCD | methionine- and choline-deficient |
| mtDNA | mitochondrial DNA |
| NAFLD | non-alcoholic fatty liver disease |
| NASH | non-alcoholic steatohepatitis |
| PDGF | platelet-derived growth factor |
| PDGFRα | PDGF receptor alpha |
| PD-L1 | programmed death ligand 1 |
| PPARγ | peroxisome proliferator-activated receptor gamma |
| SASP | senescence-associated secretory phenotype |
| PSC | primary sclerosing cholangitis |
| SK1 | sphingosine kinase 1 |
| TGF-β1 | transforming growth factor beta 1 |
| TNFα | tumor necrosis factor alpha |
| VEGF | vascular endothelial growth factor |